Quantcast

Latest Parkinson's disease Stories

2014-04-16 08:28:05

KANSAS CITY, Mo., April 16, 2014 /PRNewswire/ -- When Jack McDonald elected to have Deep Brain Stimulation (DBS) surgery after more than a decade of watching his tremors and other symptoms get progressively worse, he saw it as a teachable moment for his grandchildren. Their reactions to his brain surgery experience were the inspiration for Poppo's Electric Brain, an educational new children's book that makes Parkinson's disease and DBS more understandable for young people. More...

2014-04-14 12:32:55

Researchers recruiting patients with mild to moderate Alzheimer's disease to participate in six week study SUN CITY, Ariz., April 14, 2014 /PRNewswire/ -- Banner Sun Health Research Institute is proud to announce it is one of just five facilities in the United States to launch a new clinical trial for patients with mild to moderate Alzheimer's disease (AD). This study, titled "Effect of NeuroAD(TM), Combined TMS Stimulation and Cognitive Training, on the cognitive function of mild to...

2014-04-11 08:24:27

LA JOLLA, Calif., April 11, 2014 /PRNewswire-iReach/ -- On March 4, 2014, ICB International, Inc., ("ICBI"), announced the development of a tracer for imaging alpha-synuclein (a-Syn) in Parkinson's-like mice at the Keystone Symposium for Parkinson disease (PD) in Keystone,Colorado. Speaking at the symposium, Dr. Anna Cartier, Associate Director of ICBI, presented scientific data and showed images for the first successful live visualization of a-Syn in the brains of mice with and...

2014-04-11 08:24:24

HAYWARD, Calif., April 11, 2014 /PRNewswire/ -- Impax Pharmaceuticals, a division of Impax Laboratories, Inc. (NASDAQ: IPXL), announced today the resubmission of Impax's New Drug Application (NDA) for RYTARY (IPX066) to the U.S. Food and Drug Administration (FDA). IPX066 is a patented extended- release capsule formulation of carbidopa and levodopa, an investigational drug for the symptomatic treatment of Parkinson's disease (PD). After discussions with the FDA, the Company has...

2014-04-10 16:22:44

PHOENIX, April 10, 2014 /PRNewswire/ -- On the eve of the 20(th) anniversary of Celebrity Fight Night, the Muhammad Ali Parkinson Center is unveiling an extensive expansion that doctors say will help thousands more patients receive care. http://photos.prnewswire.com/prnvar/20140410/LA03005 The Center is the primary beneficiary of Celebrity Fight Night, an annual fundraising gala that will be held this year in Phoenix on April 12. Celebrity Fight Night attracts generous...

2014-04-10 08:28:50

DUODOPA improves quality of life for those with advanced stages of disease MONTREAL, April 10, 2014 /CNW/ - AbbVie today announced that a new treatment called DUODOPA(® )(levodopa/carbidopa intestinal gel) is now available to Canadians with advanced Parkinson's disease. Currently, more than 100,000 Canadians live with Parkinson's - a progressive, incurable neurological disorder that can significantly affect the quality of life of patients, their families and caregivers. DUODOPA is approved...

Parkinson's Patients May Retain Independence Using Google Glass
2014-04-09 13:40:57

Enid Burns for redOrbit.com - Your Universe Online Researchers as Newcastle University in the UK are studying how Google Glass can be used as an assistive aid to help people with Parkinson's disease -- the wearable technology might help patients retain their independence. University researchers received five pairs of Google Glass as a donation from Google. The wearables allow researchers to test how people with long-term health conditions can use Glass. The University's Digital...

2014-04-08 08:32:16

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/2pf8dt/neuroprotection) has announced the addition of a new report "Neuroprotection - Drugs, Markets and Companies" [http://www.researchandmarkets.com/research/2pf8dt/neuroprotection ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report describes the role of neuroprotection in acute disorders such as stroke and injuries...

2014-04-04 12:27:48

DUBLIN, Apr. 04, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/sbjkkl/deep_brain ) has announced the addition of the "Deep Brain Stimulation Devices Market for Parkinson's Disease - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) A rise in ageing population has been found to be the major causative factor for development of Parkinson's...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related